Chiwei Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Targeting UBE2T by β-elemene inhibits prostate cancer stem cells and bone metastasis by blocking the TRIM28/pGSK3β/β-catenin signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: October 15, 2025
Sanhuang Fukang oil alleviates X-ray-induced skin injury by reducing inflammation and apoptosis: an in vivo study.
Journal: Frontiers in pharmacology
Published: September 23, 2025
Identification of aging-related biomarkers and immune infiltration analysis in renal stones by integrated bioinformatics analysis.
Journal: Scientific reports
Published: September 25, 2024
Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.
Journal: Chinese journal of natural medicines
Published: December 12, 2023
System analysis identifies UBE2C as a novel oncogene target for adrenocortical carcinoma.
Journal: PloS one
Published: April 15, 2023
Icariin inhibits prostate cancer bone metastasis and destruction via suppressing TAM/CCL5-mediated osteoclastogenesis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 08, 2023
Isoliensinine suppresses bone loss by targeted inhibition of RANKL-RANK binding.
Journal: Biochemical pharmacology
Published: January 23, 2023
Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity.
Journal: Frontiers in pharmacology
Published: August 10, 2022
Acupressure versus parecoxib sodium in acute renal colic: A prospective cohort study.
Journal: Frontiers in medicine
Published: June 14, 2022
Formation of pre-metastatic bone niche in prostate cancer and regulation of traditional chinese medicine.
Journal: Frontiers in pharmacology
Published: March 16, 2022
Do disease status and race affect the efficacy of zoledronic acid in patients with prostate cancer? A systematic review and meta-analysis of randomized control trials.
Journal: PloS one
Published: November 25, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026